Skip to content

Scleroderma: What is the disease where tissue hardens?

6 min read

Affecting hundreds of thousands of people in the U.S. alone, scleroderma is the disease where tissue hardens. This chronic autoimmune condition, derived from the Greek words for “hard” and “skin,” involves the overproduction of collagen, leading to a range of challenging symptoms.

Quick Summary

The disease where tissue hardens is called scleroderma, an autoimmune disorder that causes the body to produce too much collagen, resulting in thickening of the skin and other connective tissues throughout the body.

Key Points

  • Autoimmune Cause: Scleroderma is an autoimmune disorder where the body's immune system attacks its own connective tissue.

  • Excess Collagen: The disease is caused by an overproduction of collagen, which leads to hardening of the skin and other tissues.

  • Two Main Types: It is classified as either localized (morphea, linear) or systemic, which is more severe and affects internal organs.

  • Common Symptoms: Symptoms often include skin thickening and tightening, joint pain, fatigue, and Raynaud's phenomenon.

  • No Cure, But Treatable: While there is no cure, various treatments and therapies can help manage symptoms and prevent complications.

  • Internal Organ Risk: Systemic sclerosis can cause life-threatening damage to vital organs like the lungs, heart, and kidneys.

In This Article

What is Scleroderma?

Scleroderma, also known as systemic sclerosis, is a chronic autoimmune disease characterized by an abnormal and excessive growth of connective tissue. Normally, the immune system protects the body, but in an autoimmune condition like scleroderma, it mistakenly attacks healthy tissue. This triggers cells to produce too much collagen, a protein that provides strength and support to connective tissues throughout the body, including the skin, muscles, and internal organs.

The name itself is telling, derived from the Greek words skleros, meaning 'hard,' and derma, meaning 'skin'. While the most visible manifestation is the thickening and tightening of the skin, this overproduction of collagen can affect many parts of the body, including the blood vessels and major organs like the lungs, heart, and kidneys.

Types of Scleroderma

Scleroderma is broadly categorized into two main types: localized and systemic. The severity and organs affected depend on the type.

Localized Scleroderma

This is the most common and typically milder form of the disease, primarily affecting the skin and sometimes the underlying muscles and bones. It rarely spreads to internal organs.

  • Morphea: This subtype causes thick, oval-shaped patches of hard, waxy skin on the trunk, face, or limbs. The patches can be reddish or purplish initially before becoming shiny and hairless. They may resolve on their own over several years.
  • Linear Scleroderma: This often appears as a single line or band of thickened skin on an arm, leg, or the forehead. More common in children, it can also affect underlying bone and muscle, potentially leading to limb deformities.

Systemic Sclerosis (Systemic Scleroderma)

This form is more serious, as it affects not only the skin but also internal organs and blood vessels. It is further divided into two subtypes:

  • Limited Cutaneous Systemic Sclerosis: Characterized by skin thickening limited to the areas below the elbows and knees, as well as the face and neck. This form often progresses slowly and can be associated with CREST syndrome, a group of symptoms including calcinosis (calcium deposits), Raynaud's phenomenon, esophageal dysfunction, sclerodactyly (tightening of finger skin), and telangiectasias (spider veins).
  • Diffuse Cutaneous Systemic Sclerosis: Affects larger areas of the skin, including the trunk and upper arms and legs. It progresses more rapidly and involves a higher risk of significant internal organ damage, particularly affecting the lungs and kidneys.

Signs and Symptoms

The symptoms of scleroderma vary widely among individuals but commonly include:

  • Skin Changes: Patches of tight, hard, or shiny skin, especially on the hands, fingers, and face. Swelling or puffiness of the hands and feet is an early sign.
  • Raynaud's Phenomenon: An exaggerated response to cold or stress where blood vessels in the fingers and toes constrict, causing them to turn white or blue before returning to normal. This is a very common early symptom.
  • Musculoskeletal Issues: Joint pain, stiffness, and swelling are common, along with muscle pain and weakness. The tightening of skin can also limit the range of motion in joints.
  • Digestive Problems: Damage to the digestive tract can cause heartburn, difficulty swallowing, bloating, constipation, or diarrhea.
  • Pulmonary (Lung) Issues: Scarring of the lung tissue (pulmonary fibrosis) can cause shortness of breath and a dry cough, while high blood pressure in the arteries of the lungs (pulmonary hypertension) can also occur.
  • Kidney Complications: A rare but serious complication is scleroderma renal crisis, involving a sudden increase in blood pressure and rapid kidney failure.

Causes and Risk Factors

The exact cause of scleroderma is unknown, but it is considered an autoimmune disorder that likely results from a combination of factors.

  • Genetic Factors: While it doesn't typically run in families, certain genes have been identified that may increase susceptibility. A family history of other autoimmune diseases may also increase risk.
  • Immune System Dysfunction: The underlying mechanism involves the immune system attacking the body's own connective tissue, which signals cells to overproduce collagen.
  • Environmental Triggers: Exposure to certain chemicals like silica dust, solvents, and some medications have been linked to an increased risk of developing scleroderma.
  • Demographics: Scleroderma is more common in women than in men and most often diagnosed between the ages of 30 and 50.

Diagnosis: How is it identified?

Diagnosing scleroderma can be challenging due to its varied symptoms, which often mimic other autoimmune diseases. A healthcare provider will typically perform a combination of evaluations:

  1. Physical Exam: The doctor will look for visible signs like skin thickening, swelling, and changes in the small blood vessels at the base of the fingernails.
  2. Blood Tests: Used to detect specific antibodies, particularly antinuclear antibodies (ANA), which are present in most people with scleroderma. Specific autoantibodies can indicate the type of scleroderma and predict potential organ involvement.
  3. Skin Biopsy: A small sample of skin from an affected area can be examined under a microscope to confirm the excessive collagen buildup and rule out other conditions.
  4. Imaging Tests: Chest X-rays, CT scans, and echocardiograms may be used to check for internal organ damage, particularly to the lungs and heart.
  5. Pulmonary Function Tests: These tests measure lung capacity and how well the lungs work, helping to assess the extent of lung involvement.
  6. Gastrointestinal Tests: An upper endoscopy or other tests can check for scarring in the esophagus and other digestive tract issues.

Treatment and Management

There is currently no cure for scleroderma, so treatment focuses on managing symptoms, preventing complications, and improving quality of life. A multidisciplinary team of specialists, including rheumatologists, dermatologists, and others, is often involved.

  • Medications: Doctors may prescribe immunosuppressants to slow the immune response and organ damage, vasodilators to improve blood flow and treat Raynaud's, and antacids for heartburn. Specific medications can address issues like pulmonary hypertension.
  • Physical and Occupational Therapy: Exercises can help maintain flexibility in stiffened joints and skin. A therapist can also provide tools and strategies for daily living.
  • Lifestyle Adjustments: Keeping the skin moisturized, avoiding triggers for Raynaud's (like cold), and managing heartburn through diet and lifestyle changes are all important.
  • Advanced Treatments: For severe cases, stem cell transplants or organ transplants may be considered.

Localized vs. Systemic Scleroderma: A Comparison

Feature Localized Scleroderma Systemic Sclerosis
Affected Areas Primarily skin, and sometimes underlying muscle and bone. Skin, and potentially multiple internal organs (lungs, heart, kidneys, GI tract).
Progression Typically mild and slow-progressing, may even resolve on its own. Often progresses more rapidly, especially the diffuse subtype.
Complications Usually limited to joint contractures or cosmetic skin changes. Can lead to serious or life-threatening organ damage, including pulmonary hypertension, kidney failure, and heart failure.
Key Subtypes Morphea and Linear Scleroderma. Limited (CREST) and Diffuse Cutaneous Sclerosis.

Outlook and Living with Scleroderma

The outlook for individuals with scleroderma varies greatly depending on the type and severity of the disease. While localized scleroderma may improve over time, systemic sclerosis is a lifelong condition requiring ongoing management. Regular monitoring by a healthcare team is crucial to detect and treat organ involvement early. Many people with scleroderma lead active, full lives with proper treatment and self-care, focusing on managing symptoms and preventing complications.

The Importance of Early Diagnosis

Because scleroderma can cause irreversible damage to organs over time, early and accurate diagnosis is critical. Prompt treatment can help minimize symptoms, slow disease progression, and limit the extent of damage to internal organs. If you notice persistent skin hardening, puffiness in the fingers, or other related symptoms, consulting a healthcare provider, ideally a rheumatologist, is essential.

Conclusion

Scleroderma is the autoimmune disease where tissue hardens due to the overproduction of collagen. It can manifest as localized skin patches or, more seriously, affect a wider range of the body's systems and organs. While there is no cure, understanding the disease, getting an early diagnosis, and working with a dedicated healthcare team are vital for effective management. Learning to live with the condition involves a combination of medical treatments, physical therapy, and careful self-care to minimize complications and maintain the best possible quality of life. For more in-depth information, you can visit the National Scleroderma Foundation.

Frequently Asked Questions

No, scleroderma is not contagious. It is an autoimmune condition, meaning it results from the body's own immune system acting abnormally, not from an infection that can be spread from person to person.

The exact cause is unknown, but researchers believe it involves a combination of genetic factors, immune system dysfunction, and environmental triggers, such as exposure to certain chemicals.

Yes, the severity of scleroderma varies widely. Localized scleroderma is typically mild and limited to the skin, while systemic sclerosis can be severe, affecting multiple internal organs.

The outlook depends heavily on which organs are affected and the extent of the damage. With modern treatment, many people with systemic sclerosis can live long, fulfilling lives, though it remains a serious chronic condition.

Yes, scleroderma can affect people of any age, including children. Linear scleroderma, a type of localized scleroderma, is more common in children.

There is currently no cure for scleroderma. However, a variety of treatments are available to help manage symptoms, control the disease, and limit further organ damage.

Raynaud's phenomenon is a condition where small blood vessels in the fingers and toes constrict in response to cold or stress. It is a very common early symptom of systemic scleroderma and is caused by the underlying vascular damage.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.